Evidence map›Paper›PMID 36745292›Full record

ArticleAngiogenesis2023

Loss of GLTSCR1 causes congenital heart defects by regulating NPPA transcription.

Fengyan Han, Beibei Yang, Yan Chen, Lu Liu, Xiaoqing Cheng, Jiaqi Huang, Ke Zhou, Dandan Zhang, Enping Xu, Maode Lai and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Angiogenesis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Fengyan Han *Department of Pathology and Women's Hospital, Research Unit of Intelligence Classification of Tumor Pathology and Precision Therapy, Chinese Academy of Medical Sciences (2019RU042), Zhejiang University School of Medicine, Hangzhou, 310058, Zhejiang, China.
Beibei Yang *Department of Pathology and Women's Hospital, Research Unit of Intelligence Classification of Tumor Pathology and Precision Therapy, Chinese Academy of Medical Sciences (2019RU042), Zhejiang University School of Medicine, Hangzhou, 310058, Zhejiang, China.
Yan ChenDepartment of Pathology and Women's Hospital, Research Unit of Intelligence Classification of Tumor Pathology and Precision Therapy, Chinese Academy of Medical Sciences (2019RU042), Zhejiang University School of Medicine, Hangzhou, 310058, Zhejiang, China.
Lu LiuDepartment of Pathology and Women's Hospital, Research Unit of Intelligence Classification of Tumor Pathology and Precision Therapy, Chinese Academy of Medical Sciences (2019RU042), Zhejiang University School of Medicine, Hangzhou, 310058, Zhejiang, China.
Xiaoqing ChengDepartment of Pathology and Pathophysiology and Department of Cardiology at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
Jiaqi HuangDepartment of Pathology and Pathophysiology and Department of Cardiology at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
Ke ZhouCenter for Stem Cells and Regenerative Medicine, Department of Orthopedic Surgery of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China.
Dandan ZhangDepartment of Pathology and Department of Medical Oncology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, Zhejiang, China.
Enping XuDepartment of Pathology and Women's Hospital, Research Unit of Intelligence Classification of Tumor Pathology and Precision Therapy, Chinese Academy of Medical Sciences (2019RU042), Zhejiang University School of Medicine, Hangzhou, 310058, Zhejiang, China.
Maode LaiCancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Bingjian LvDepartment of Pathology and Women's Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, Zhejiang, China.
Hongqiang ChengDepartment of Pathology and Pathophysiology and Department of Cardiology at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310058, China. Hqcheng11@zju.edu.cn.
Honghe ZhangDepartment of Pathology and Women's Hospital, Research Unit of Intelligence Classification of Tumor Pathology and Precision Therapy, Chinese Academy of Medical Sciences (2019RU042), Zhejiang University School of Medicine, Hangzhou, 310058, Zhejiang, China. honghezhang@zju.edu.cn.
Zhejiang University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNSecond Affiliated Hospital of Zhejiang University · CNSir Run Run Shaw Hospital · CNHangzhou Normal University · CNWomen's Hospital, School of Medicine, Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precise and specific spatiotemporal domains of gene expression regulation are critical for embryonic development. Recent studies have identified GLTSCR1 as a gene transcriptional elongation regulator in cancer research. However, the function of GLTSCR1, especially in embryonic development, remains poorly understood. Here, we found that GLTSCR1 was essential for cardiac development because Gltscr1 knockout (Gltscr1

Indexed as

Atrial Natriuretic FactorChromosomal Proteins, Non-HistoneHeart Defects, CongenitalTumor Suppressor ProteinsAnimalsEmbryonic DevelopmentFemaleGene Expression RegulationMicePregnancyTranscription FactorsAtrial Natriuretic FactorChromosomal Proteins, Non-HistoneNppa protein, mouseTranscription FactorsTumor Suppressor ProteinsCHDEmbryonic developmentGLTSCR1NPPA

Identifiers

PMID36745292
PMCPMC10119265
OpenAlexW4319295102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.